Drug Trial Radar · NCT00663130
Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)
Last checked: Nov 19, 2026Latest source record: Oct 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
759
Actual
Start
Apr 2004
Primary completion
Jul 2004
Study completion Jul 2004
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- Collaborators
- GlaxoSmithKline
- First posted
- Apr 22, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED
Conditions
- Erectile Dysfunction
Interventions
Levitra (Vardenafil, BAY38-9456)Drug
Vardenafil 10mg, taken orally within 1 hour prior to sexual intercourse
TadalafilDrug
Tadalafil 10mg, taken orally within 1 hour prior to sexual intercourse
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sexual Encounter Profile Question 3 (SEP-3)Time frame: 4 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.